Summit Therapeutics Inc (SMMT) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...
Summit Therapeutics Inc (SMMT) reports a robust cash reserve and debt-free status, while advancing key clinical trials and ...
Why Summit Therapeutics Inc. (SMMT) Went Down On Monday?
We recently published a list of 10 Stocks Drop The Most Amid Investor Caution. In this article, we are going to take a look ...
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 24, 2025 Operator: Good morning and welcome to Summit Therapeutics Fourth Quarter ...
The Pharma Letter17h
Summit inks ADCs deal with Pfizer
Florida, USA-based Summit Therapeutics saw its share rise 6.2% to $23.50 pre-market on the news of a clinical trial ...
Investing Snacks22h
Pfizer and Summit Join Forces in Cancer Drug Trials
Pfizer has partnered with Summit Therapeutics to evaluate ivonescimab, a PD-1/VEGF bispecific antibody, in combination with ...
Pfizer (PFE) Gets a Hold from Bernstein
Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunovant (IMVT), Summit Therapeutics (SMMT) and Outset Medical (OM)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immunovant (IMVT – Research Report), Summit Therapeutics ...
The Pharma Letter13h
FDA lifts clinical hold on Entrada’s ENTR-601-44 study
The US Food and Drug Administration (FDA) has lifted the clinical hold on ENTR-601-44 and provided authorization to initiate ELEVATE-44-102, a Phase Ib multiple ascending dose (MAD) clinical study of ...